Michelle Burns, LCPC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 498 Essex St, Bangor, ME 04401 Phone: 207-992-2535 |
April Archibald, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 43 Columbia St, Suite 12, Bangor, ME 04401 Phone: 207-573-4126 Fax: 207-573-4126 |
Mrs. Samantha Lee Ahearn, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 689 Odlin Rd, Bangor, ME 04401 Phone: 207-947-6800 |
Allan P Walker, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 659 Hogan Rd, Bangor, ME 04401 Phone: 207-973-0400 |
Martha Mary S. Ranger, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 268 Stillwater Avenue, Acadia Hospital Corp., Bangor, ME 04401 Phone: 207-973-6297 Fax: 207-973-6985 |
Katrina St Louis Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 21 Main St Ste 301, Bangor, ME 04401 Phone: 207-631-2201 Fax: 207-631-2203 |
Olena Kenney, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 689 Odlin Rd Ste 1, Bangor, ME 04401 Phone: 207-947-6800 Fax: 207-947-6872 |
Renee Carmichael, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 268 Stillwater Ave, Bangor, ME 04401 Phone: 207-973-6100 |
Robyn Lynn Gallant, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 498 Essex St Ste 104, Bangor, ME 04401 Phone: 207-356-7229 |
Robyn L Greene, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 29 Franklin St, Bangor, ME 04401 Phone: 207-942-3816 Fax: 207-561-4725 |
Megan Poto Counselor - Professional Medicare: Medicare Enrolled Practice Location: 30 Summer St, Ste 5, Bangor, ME 04401 Phone: 207-210-4052 |
Jacqueline Louise Davis Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 253 Hammond St, Bangor, ME 04401 Phone: 207-941-1612 |
Ms. Libby Virginia Hanley, MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 268 Stillwater Ave, Bangor, ME 04401 Phone: 207-973-6100 |
Jessica Bump, LCPC-C Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 40 Summer St, Bangor, ME 04401 Phone: 207-945-4240 |
Bruce A Campbell Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 253-255 Hammond St., Bangor, ME 04401 Phone: 207-941-1612 Fax: 207-941-1634 |
Jayne Elizabeth Gilbert Thibodeau, M.ED. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1 College Cir, 101 Peabody Hall, Bangor, ME 04401 Phone: 207-941-7184 |
Mrs. Ann Marie Soule, LCPC C Counselor - Professional Medicare: Medicare Enrolled Practice Location: 268 Stillwater Avenue, Acadia Hospital Corp, Bangor, ME 04401 Phone: 207-973-6100 Fax: 207-973-6109 |
Mrs. Brooke Hackett, LMSW-CC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 40 Summer St, Bangor, ME 04401 Phone: 207-944-8074 Fax: 207-990-3660 |
Haley Joyce Beem, LCPC, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 96 Harlow St Ste 381, Bangor, ME 04401 Phone: 207-951-6259 |
Shannon Charette Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 557 Hammond St, Bangor, ME 04401 Phone: 207-973-0505 |
News Archive
News reports explore the constitutional questions to be explored in the high court's review of the health law and the most likely potential outcomes.
The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2011 revenue of $28.5 million, up 24% compared to revenue of $23.0 million in the same period of fiscal 2010.
GTx, Inc. announced the presentation of preclinical studies evaluating GTx-758, a selective estrogen receptor alpha agonist being developed for first line treatment of advanced prostate cancer, and GTx-230, a novel microtubule polymerization inhibitor.
The composition of intestinal bacteria and other micro-organisms-called the gut microbiota-changes over time in unhealthy ways in black men who are prediabetic, a new study finds. The results will be presented Friday at the Endocrine Society's 97th annual meeting in San Diego.
› Verified 6 days ago